Tokai Pharmaceuticals Doses First Patient in a Phase 2 Study of Galeterone in …

Published December 15, 2012

Tokai Pharmaceuticals Doses First Patient in a Phase 2 Study of Galeterone in …

Filed under: drug treatment programs maryland

ARMOR2 is being conducted globally at leading prostate cancer treatment centers. The study is being led by co-principal investigators Bruce Montgomery, M.D., associate professor of medical oncology at the University of Washington School of Medicine and …
Read more on FierceBiotech

Metformin linked to improved ovarian cancer survival

Filed under: drug treatment programs maryland

By Will Boggs, MD. NEW YORK (Reuters Health) – Metformin intake may be associated with improved survival in women with ovarian cancer, according to new research. "This study was essentially a hypothesis generating study," Dr. Vijayalakshmi Shridhar …
Read more on ModernMedicine

ARRY-520 Shows Encouraging Early Results For Relapsed And Refractory …

Filed under: drug treatment programs maryland

“ARRY-520 shows promising activity in combination with dexamethasone in heavily pretreated myeloma patients,” said Dr. Jatin Shah, from the MD Anderson Cancer Center in Houston and lead investigator of both studies. Based on their findings, the study …
Read more on The Myeloma Beacon